SEC 13F Intelligence

Baker Avenue Asset Management, LP / ABBV

Baker Avenue Asset Management, LP’s Abbvie Inc Position

Does Baker Avenue Asset Management, LP own Abbvie Inc (ABBV)? Yes — 109.4K shares worth $24M (+0.54% of its 13F portfolio) as of Q1 2026, up from 109.4K shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
109.4K
% of Portfolio
+0.54%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $1MQ2 ’19: $6MQ3 ’19: $8MQ4 ’19: $9MQ4 ’19Q1 ’20: $6MQ2 ’20: $17MQ3 ’20: $16MQ4 ’20: $22MQ4 ’20Q1 ’21: $23MQ2 ’21: $25MQ3 ’21: $25MQ4 ’21: $35MQ4 ’21Q1 ’22: $34MQ2 ’22: $17MQ3 ’22: $16MQ4 ’22: $19MQ4 ’22Q1 ’23: $11MQ2 ’23: $11MQ3 ’23: $12MQ4 ’23: $14MQ4 ’23Q1 ’24: $17MQ2 ’24: $17MQ3 ’24: $22MQ4 ’24: $19MQ4 ’24Q1 ’25: $22MQ2 ’25: $20MQ3 ’25: $25MQ4 ’25: $25MQ4 ’25Q1 ’26: $24Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026109.4K$24M+0.54%
Q4 2025109.4K$25M+0.58%
Q3 2025109.7K$25M+0.61%
Q2 2025105.4K$20M+0.56%
Q1 2025105.8K$22M+0.69%
Q4 2024105.6K$19M+0.57%
Q3 2024110.2K$22M+0.69%
Q2 2024101.3K$17M+0.59%
Q1 202491.3K$17M+0.65%
Q4 202390.0K$14M+0.61%
Q3 202382.9K$12M+0.62%
Q2 202380.3K$11M+0.54%
Q1 202371.1K$11M+0.61%
Q4 2022114.7K$19M+1.11%
Q3 2022119.8K$16M+1.01%
Q2 2022110.8K$17M+1.12%
Q1 2022211.4K$34M+1.75%
Q4 2021255.1K$35M+1.73%
Q3 2021232.0K$25M+1.43%
Q2 2021223.8K$25M+1.43%
Q1 2021210.7K$23M+1.40%
Q4 2020206.1K$22M+1.50%
Q3 2020178.1K$16M+1.20%
Q2 2020168.9K$17M+1.37%
Q1 202075.0K$6M+0.68%
Q4 2019104.9K$9M+0.67%
Q3 2019108.5K$8M+0.65%
Q2 201984.7K$6M+0.50%
Q1 201916.4K$1M+0.11%
Q4 201830.8K$3M+0.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Baker Avenue Asset Management, LP’s full portfolio or all institutional holders of ABBV.